Monitoring body weight and physical activity in cancer patients
Patient Recorded Indexing Measurements
Academisch Ziekenhuis Maastricht · NCT05899205
This study is trying to see how monitoring weight and physical activity at home can help people with certain types of cancer better manage their health during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Academisch Ziekenhuis Maastricht (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Maastricht and 1 other locations) |
| Trial ID | NCT05899205 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with pancreatic, esophageal, gastric, ovarian, or colorectal cancer who are scheduled for neo-adjuvant chemotherapy or primary surgery. Participants will receive a weight scale and an accelerometer to monitor their body weight and physical activity at home. The study aims to collect objective data on weight changes and activity levels, which are crucial for understanding and managing cancer cachexia. By utilizing advanced technology for data collection, the study seeks to improve the accuracy of cachexia diagnosis and management.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with specific types of cancer and scheduled for surgery or chemotherapy.
Not a fit: Patients with severe comorbidities or those who are bedridden or in a wheelchair may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better management of cancer cachexia, improving patients' quality of life and treatment outcomes.
How similar studies have performed: While the approach of using technology for monitoring weight and activity in cancer patients is gaining traction, this specific methodology is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 * Diagnosed with cancer * Planned for curative-intent surgery or neo-adjuvant chemotherapy Exclusion Criteria: * ASA-classification V, * severe liver cirrhosis Child grade C, * end stage renal disease requiring dialysis, * severe heart disease New York Heart Association class IV, * chronic obstructive pulmonary disease (COPD) requiring (home)oxygen therapy, * Patients must be "mobile". They may not be bedridden or in a wheelchair.
Where this trial is running
Maastricht and 1 other locations
- Maastricht University Medical Center+ — Maastricht, Netherlands (RECRUITING)
- Zuyderland Medical Center — Sittard, Netherlands (RECRUITING)
Study contacts
- Principal investigator: Steven Olde Damink, PhD, MSc., M.D. — Maastricht University Medical Center
- Study coordinator: Nicole Hildebrand, M.D.
- Email: nicole.hildebrand@mumc.nl
- Phone: +31 (0)43-3881584
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cachexia, Cancer, Weight, Body, Cancer cachexia, Physical activity, Body weight, Body composition, Functional mobility